EyePoint Pharmaceuticals's total assets for Q4 2025 were $364.00M, an increase of 44.62% from the previous quarter. EYPT total liabilities were $57.88M for the fiscal quarter, a 12.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.